Staying indoors is currently the only way to reduce the spread of new coronaviruses. The longer we avoid others, the less likely we are to be infected with COVID-19. We already know that the virus is highly contagious, and studies have shown that asymptomatic patients can also transmit the virus. What’s more, there may be some rare cases outside, and the pathogen will remain highly active within a few weeks, with the current maximum record of 49 days.
We stay indoors while helping doctors and first responders. Some countries have been overwhelmed by the number of patients treated in a short period of time, and communities will continue to experience harsh realities for some time. But life will eventually return to “normality”. Even so, we risk more outbreaks. Only targeted treatments like vaccines can eradicate the virus. Before that, we need a different COVID-19 detection method than we do today. The FDA has just approved the first such test.
COVID-19 testing is widely performed around the world and will not be tested in many places unless you have severe symptoms. Countries such as Singapore, South Korea, Germany and Iceland have emerged as the standout in enhanced testing to beat the epidemic.
South Korea has greatly flattened the curve by detecting confirmed cases of contact tracing and isolation. Germany, on the other hand, detects the disease early. With nearly 85,000 cases, Germany is the fourth-largest country in the number of COVID-19 patients. But its COVID-19 screening program helped them reduce mortality.
We’ve explained before that in the future, the world needs a second COVID-19 test, a test that tells you if you’ve ever had the disease. Early COVID-19 immunity studies have shown promise. Recovering patients are likely to fight a second infection and do not spread the disease. That’s why testing antibodies, which prove that the immune system is successful against tiny particles of SARS-CoV-2, will be key in the coming months.
If immunity is long-lasting, as some believe, or if it gets us through next year, when the first vaccines arrive, the survivors of COVID-19 will be able to resume their daily lives. They will be able to go out, return to work in public places and visit loved ones. The risk of being infected or infected with others will be greatly reduced and new outbreaks can be avoided.
The FDA has just approved the first antibody-based COVID-19 test kit. The blood test was produced by the biotech company Cellex and must be performed in a professional laboratory. But the results can be produced in 15 to 20 minutes.
Health care providers, first responders, and other necessary staff may be among the first to be tested for antibodies to determine the risk of a new TYPE of COVID-19 outbreak. In the future, more people should be able to undergo similar tests. Let’s not forget that not all people recovering from COVID-19 will be tested. Some of them may never develop any symptoms, and without immunity testing, they will never know they have the disease.
The United States is not the only country in the future that is concerned about COVID-19 immunity testing. German researchers are studying the deployment of “immune passports” for those with the disease so they can return to work faster than others. This will be a way to speed up community recovery and reduce local restrictions. According to the Guardian, Germany will conduct research on about 100,000 volunteers in mid-April to examine antibodies. Tests will then be repeated in larger population samples to track the actual progress of the outbreak.
“Those who are immune can get a vaccination pass, for example, to allow them to be exempt from restricting their activities,” said Gerard Krause, head of epidemiology at the Helmholtz Center for Infection Research in Brunswick. This is only a recommendation, and the German government has not issued any formal guidelines.
The British government was once a supporter of COVID-19 “group immunization” and plans to issue an “immune passport” in the future. “We are studying immunization cards,” Matt Hancock, Britain’s health secretary, said on Thursday. “People who have had this disease get antibodies, and then have immunity, and they can show it to get back to normal life as much as possible.” “
He acknowledged that it was “too early for science to prove this” and could not be sure. The UK has ordered millions of antibody tests, but they have proved ineffective, so the government has not approved their use. “But we want the results later to be reliable enough to give people the confidence to use them.” The official said.